These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. Amano H; Miyamoto N; Shimura H; Sato DK; Fujihara K; Ueno S; Nakamura R; Ueno Y; Watanabe M; Hattori N; Urabe T BMC Neurol; 2014 Nov; 14():224. PubMed ID: 25434485 [TBL] [Abstract][Full Text] [Related]
4. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting. Bilodeau PA; Kumar V; Rodriguez AE; Li CT; Sanchez-Alvarez C; Thanarajasingam U; Zalewski NL; Flanagan EP Mult Scler; 2020 Jul; 26(8):997-1000. PubMed ID: 31621483 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. Cobo-Calvo Á; Sepúlveda M; Bernard-Valnet R; Ruiz A; Brassat D; Martínez-Yélamos S; Saiz A; Marignier R Mult Scler; 2016 Mar; 22(3):312-9. PubMed ID: 26209592 [TBL] [Abstract][Full Text] [Related]
6. [A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions]. Matsumoto A; Kaneko K; Takahashi T; Nakashima I; Hisanaga K; Nagano I Rinsho Shinkeigaku; 2017 Nov; 57(11):729-732. PubMed ID: 29070750 [TBL] [Abstract][Full Text] [Related]
7. A case of anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse myelitis. Sugimoto T; Ishibashi H; Hayashi M; Tachiyama K; Fujii H; Kaneko K; Takahashi T; Kurokawa K; Yamawaki T Mult Scler Relat Disord; 2018 Oct; 25():128-130. PubMed ID: 30071506 [TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. Tantsis EM; Prelog K; Alper G; Benson L; Gorman M; Lim M; Mohammad SS; Ramanathan S; Brilot F; Dale RC; Dev Med Child Neurol; 2019 Sep; 61(9):1108-1116. PubMed ID: 30537075 [TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
13. Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases. Wang C; Narayan R; Greenberg B Pediatr Neurol; 2018 Sep; 86():42-45. PubMed ID: 30077551 [TBL] [Abstract][Full Text] [Related]
14. Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study. Chen C; Liu C; Fang L; Zou Y; Ruan H; Wang Y; Cui C; Sun X; Peng L; Qiu W J Neurol Sci; 2019 Oct; 405():116430. PubMed ID: 31465985 [TBL] [Abstract][Full Text] [Related]
15. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association. Di Pauli F; Morschewsky P; Berek K; Auer M; Bauer A; Berger T; Bsteh G; Rhomberg P; Schanda K; Zinganell A; Deisenhammer F; Reindl M; Hegen H Front Immunol; 2021; 12():769653. PubMed ID: 34737756 [TBL] [Abstract][Full Text] [Related]
16. [Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic's disease: A case report]. Oji S; Yamaga T; Suzuki M; Tanaka S; Fukaura H; Nomura K Rinsho Shinkeigaku; 2020 Mar; 60(3):219-222. PubMed ID: 32101847 [TBL] [Abstract][Full Text] [Related]
17. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies. Maillart E; Durand-Dubief F; Louapre C; Audoin B; Bourre B; Derache N; Ciron J; Collongues N; de Sèze J; Cohen M; Lebrun-Frenay C; Hadhoum N; Zéphir H; Deschamps R; Carra-Dallière C; Labauge P; Kerschen P; Montcuquet A; Wiertlewski S; Laplaud D; Runavot G; Vukusic S; Papeix C; Marignier R; J Neuroinflammation; 2020 Apr; 17(1):128. PubMed ID: 32326965 [TBL] [Abstract][Full Text] [Related]
18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Management of Transverse Myelitis Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Boyinepally K; Marellapudi A; Nawras Y; Fatima R; Altorok N Am J Ther; 2024 Jul-Aug 01; 31(4):e505-e508. PubMed ID: 38976541 [No Abstract] [Full Text] [Related]